Characteristic | Males (n = 191) | Females (n = 613) | Total (n = 810a) |
---|---|---|---|
Age groups, in years | |||
< 75 | 61.4% (49.3–73.6) | 52.6% (35.9–69.4) | 57.0% (46.4–67.7) |
75–84 | 38.6% (27.7–49.4) | 46.1% (34.3–57.8) | 43.9% (34.9–52.8) |
85+ | 59.4% (45.6–73.1) | 36.1% (26.1–46.0) | 39.2% (29.8–48.6) |
Level of care dependency | |||
None/I | 55.3% (44.1–66.4) | 36.7% (27.0–46.3) | 41.3% (32.7–49.8) |
II | 56.5% (45.8–67.1) | 40.6% (30.2–51.0) | 44.2% (34.9–53.4) |
III | 42.9% (29.5–56.3) | 44.8% (32.9–56.7) | 43.9% (34.7–53.1) |
Number of scheduled medications | |||
Q1 (0–4) | 52.6% (35.9–69.4) | 32.1% (21.0–43.2) | 36.9% (26.0–47.9) |
Q2 (5–6) | 39.5% (23.3–55.8) | 36.8% (27.1–46.5) | 37.2% (28.0–46.4) |
Q3 (7–9) | 57.8% (45.5–70.1) | 45.9% (35.7–56.2) | 48.6% (40.3–56.9) |
Q4 (10+) | 59.3% (46.4–72.1) | 49.1% (36.3–61.9) | 51.4% (41.1–61.8) |
Length of residence | |||
≤ 180 days | 81.6% (64.3–98.8) | 55.9% (40.1–71.6) | 65.7% (52.2–79.3) |
181+ days | 44.7% (37.1–52.4) | 38.3% (29.8–46.8) | 39.5% (32.0–47.0) |
Total | 52.4% (45.8–58.9) | 40.3% (31.9–48.7) | 43.1% (35.6–50.5) |